Dr. Ahmed Abdelrahman shows a novel step to extend the Ahmed glaucoma valve tube inside the eye when it is retracted, such as in growing children.

This week in the news, increases in myopia may lead to increased myopic macular degeneration, severe chronic kidney disease puts patients at risk for glaucoma, and glaucoma medication adherence is linked to racial and ethnic disparities.

Dr. Ronald Fellman provides an overview of approaches to managing glaucoma and how they have changed over time.

Dr. Matthew Emanuel describes the ideal patient for gonioscopy-assisted transluminal trabeculotomy (GATT), key pearls for success, and why he chooses GATT over other types of minimally invasive glaucoma surgery (MIGS).

The MINIject glaucoma drainage device, composed of a biocompatible porous silicone material, is a novel implant developed to target the suprachoroidal space. Six-month data have been previously published; this study evaluated the efficacy and safety of the MINIject device over a 2-year follow-up period.

Dr. Sharon L. Jick discusses glaucoma topics in a 3-part series for comprehensive ophthalmologists.

This prospective study was conducted to evaluate the progression and magnitude of change in IOP in patients undergoing surgery for glaucoma.

This retrospective interventional cohort study evaluated the effect of primary needling at the time of insertion of the XEN microstent on postoperative needling rates.

A once-daily dose of the novel drug omidenepag isopropyl showed the same efficacy as twice-daily dosing and was more tolerable for patients.